Abstract
This work reports the binding capacity of various chemicals (so-called endocrine disruptors) to recombinant human steroid receptors (hERα, hPR and hAR). The tested chemicals are organochlorine insecticides (DDT and its metabolites, methoxychlor, aldrin, dieldrin, chlordecone, lindane, trichlorobenzene), estrogenic insecticides (endosulfan, toxaphene, nonachlor), herbicides (alachlor and atrazine), fungicides (benomyl and vinclozolin), industrial chemicals (nonylphenol, bisphenol A, diphenylphtalate), antioxidants (butylated hydroxyanisol) and some phytoestrogens. Except for phytoestrogens, most of the tested chemicals (DDT and its metabolites, aldrin, α- and β-endosulfan, toxaphen, trans-nonachlor) show higher affinities for hPR than for hERα, indicating that the interaction with the progesterone receptor could contribute to the endocrine-disrupting effects imputed to these chemicals. We propose to use binding assays using recombinant human steroid receptors as screening tools for the detection of endocrine disruptors in various samples.
Similar content being viewed by others
References
Bowerman WW, Best DA, Grubb TG, Sikarskie JG, Giesy JP (2000) Chemosphere 41:1569–1574
Vos JG, Dybing E, Greim HA, Ladefoged O, Lambre C, Tarazona JV, Brandt I, Vethaak AD (2000) Crit Rev Toxicol 30:71–133
Guillette LJ, Gunderson MP (2001) Reproduction 122:857–864
Sharpe RM (2001) Toxicol Lett 120:221–232
Lebel G, Dodin S, Ayotte P, Marcoux S, Ferron LA, Dewailly E (1998) Fertil Steril 69:221–228
Ohlson C-G, Hardell L (2000) Chemosphere 40:1277–1282
Jensen TK, Toppari J, Keiding N Skakebaek NE (1995) Clin Chem 41:1896–1901
Skakkebaek NE (1998) Adv Exp Med Biol 444:1–2
Murray TJ, Lea RG, Abramovitch DR, Haites NE, Fowler PA (2001) Early Pregnancy V:8–112
Jongbloet PH, Roleveld N, Groenewoud HMM (2002) Environ Health Perspect 110:1–3
Mendes JJA (2002) Food Chem Toxicol 40:781–788
Multigner L, Oliva A (2002) Cad Saude Publica 18 :403–412
Soto AM, Chung LC, Sonnenschein C (1994) Environ Health Perspect 102:380–383
Soto AM, Sonnenschein C, Chung LC, Fernandez MF, Olea N, Olea Serrano F (1995) Environ Health Perspect 103:113–122
Whithe R Jobling S Hoare SA Sumpter JP Parker MG(1994) Endocrinology 135:175–182
Kelce WR, Stone CR, Laws SC, Gray LE, Kempainen JA, Wilson EM (1995) Nature 375:581–585
Scippo ML, Van De Weerdt C, Willemsen P, François J-M Rentier-Delrue F, Muller M, Martial JA, Maghuin-Rogister G (2002) Anal Chim Acta 473:135–141
Kuiper GGJM, Lemmen JG, Carlsson BO, Corton C, Safe SH, van der Saag PT, van der Burg B, Gustafsson J-A (1998) Endocrinology 139:4252–4263
Ousterhout J, Struc F, Nelson JA 1981 Biochem Pharmacol 30:2869-2871
Klotz DM, Ladlie BL, Vonier PM, McLachlan JA, Arnold SF (1997) Mol Cell Endocrinol 129:63–71
Sumida K, Saito K, Ooe N, Isobe N, Kaneko H, Nakatsuka I (2001) Toxicol Lett 118:147–155
Soto AM, Justicia H, Wray JW, Sonnenschein C (1991) Environ Health Perspect 92:167–173
Vonier PM, Crain DA, MacLachlan JA, Guillette LJ, Arnold SF (1996) Environ Health Perspect 104:1318–1322
Jin L, Tran Q, Ide CF, McLachlan JA, Arnold SF (1997) Biochem Biophys Res Commun 233 :139–146
Tran DQ, Klotz DM Ladlie BL, Ide CF, McLachlan JA, Arnold SF (1996) Biochem Biophys Res Commun 229:518–523
Collins BM, McLachlan JA, Arnold SF (1997) Steroids 2:365–372
Willemsen P, Scippo M-L, Maghuin-Rogister G, Martial JA, Muller M (2003) ABC, this issue
Bagga D, Anders KH, Wang H, Roberts E, Glaspy JA (2000) J Natl Cancer Inst 92:750–753
Hoyer AP, Jorgensen T, Grandjean P, Hartvig HB (2000) Cancer Causes Control 11:177–184
Wolff M, Zeleniuch-Jacquotte A, Dubin N, Toniolo P (2000) Cancer Epidemiol Biomarkers Prev 9:271–277
Bauer ERS, Meyer HHD, Stahlschmidt-Allner P, Sauerwein H (1998) Analyst 123:2485–2487
Bauer ERS, Bitsch N, Brunn H, Sauerwein H, Meyer HHD (2002) Chemosphere 46:1107–1115
Kelce WR, Wilson EM (1997) J Mol Med 75:198–207
Sohoni P Sumpter JP (1998) J Endocrinol 158 :327–339
Maness SC, McDonnell DP, Gaido KW (1998) Toxicol Appl Pharmacol 151:135–142
Gaido KW, Maness SC, McDonnell DP, Dehal SS, Kupfer D, Safe S (2000) Mol Pharmacol 58:852–858
Klotz DM, Beckman BS, Hill SM, McLachlan JA, Walters MR Arnold SF (1996) Environ Health Perspect 104:1084–1089
Krishnan AV, Stathis P, Permuth SF, Tokes L, Feldman D (1993) Endocrinology 132:2279–2286
Stelzer A, Chan HM (1999) Toxicology 138:69–80
Kelce WR, Monosson E, Gamcsik MP, Laws SC, Gray LE (1994) Toxicol Appl Pharmacol 126:276–285
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Scippo, ML., Argiris, C., Van De Weerdt, C. et al. Recombinant human estrogen, androgen and progesterone receptors for detection of potential endocrine disruptors. Anal Bioanal Chem 378, 664–669 (2004). https://doi.org/10.1007/s00216-003-2251-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-003-2251-0